在癌症研究中的表观遗传分析
Lakshita Tyagi1, Umesh Kumar2, Shreeja Mishra1
1Department of Biosciences, IMS Ghaziabad University Courses Campus, NH9, Adhyatmik Nagar, Ghaziabad, Uttar Pradesh, India.
Methods in cell biology
|October 1, 2025
概括
表观遗传变化,与遗传变化一起,驱动癌症的进展. 针对这些表观遗传机制,如DNA甲基化和基因素修饰,为各种癌症提供了有希望的新疗法策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 癌症是第二致命的疾病,由瘤基因和瘤抑制基因的遗传突变驱动.
- 表观遗传变化,包括DNA甲基化和基因组修饰,对癌症的发展和进展有显著的贡献.
- 遗传和表观遗传变化之间的相互作用加速了癌症的传播,并提出了新的治疗点.
研究的目的:
- 审查表观遗传修饰在癌症中的作用.
- 讨论当前和新兴的表观遗传癌症疗法.
- 突出针对表观遗传调节者的潜力,以改善癌症治疗结果.
主要方法:
- 关于癌症遗传学和表观遗传学的科学文献的综述.
- 对表观遗传变化的分析,如DNA甲基化和基因组修饰.
- 检查针对DNMTs,HATs和HDACs等表观遗传酶的治疗策略.
主要成果:
- 遗传变化 (例如,费城染色体,Ras突变) 和表观遗传变化 (基因组修饰,DNA甲基化) 是癌症的关键驱动因素.
- 表观遗传药物,包括DNMT抑制剂 (Decitabine,Azacytidine) 和HDAC抑制剂 (Panobistat,Vorinostat),已被批准用于某些血液癌症.
- 针对HATs,HDACs,脱甲基酶和基因素甲基转移酶的新型抑制剂在限制癌细胞增殖方面表现有前途.
结论:
- 表观遗传修饰在癌症进展中至关重要,并代表了可行的治疗点.
- 表观遗传疗法为治疗具有挑战性的癌症提供了一个有希望的途径,目前正在进行的临床试验评估其疗效和安全性.
- 向表观遗传调节器为改善瘤学患者的治疗结果提供了希望.
相关概念视频
Epigenetic Regulation
3.7K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.7K
Epigenetic Regulation
33.5K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
33.5K
Cancer Survival Analysis
648
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
648
Cancer-Critical Genes II: Tumor Suppressor Genes
9.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.4K
Histone Modification
15.9K
The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
15.9K


